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Background
Little is known on the short-term or medium-term psy-
chological and psychiatric sequelae following Stevens
Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)
and drug reaction with eosinophilia and systemic symp-
toms (DRESS). Based on this we did a prospective study
designed to assess anxiety and depression in patients with
severe cutaneous adverse drug reactions by indicating
higher Hospital anxiety and depression scale (HADS).
Methods
We prospectively assessed 46 consecutive admissions with
SJS, TEN and DRESS at a tertiary hospital in South Africa
at 6 weeks and 6 months post discharge from hospital. We
used a validated scoring system Hospital anxiety and
depression scale (HADS) to assess anxiety and depressive
in this cohort.
Results
Forty-six patients were seen at six weeks and (n=38) 83%
were reviewed at 6 months. Seventy-six percent of the par-
ticipants were females and 82% were HIV-infected. Anxiety
and depression were diagnosed in 37% and 30% respec-
tively with six weeks with 8.6% exhibiting mixed anxiety
and depressive symptoms. In comparison, at six months
13% had anxiety, 55% were depressed and 18.4% showed
mixed anxiety and depressive symptoms. Nine and eight
percent respectively at six weeks and six months warranted
referral to a psychiatrist. Twenty-five percent of patients
had anxiety and 40% had depression throughout the whole
six months. The incidence of anxiety and depression was
significantly associated with severity of the drug reaction.
Interpretation
SJS/TEN and DRESS are associated with anxiety and
depression for at least 6 months. SJS/TEN showed higher
degree of anxiety and depression compares to DRESS. Our
findings should help to improve awareness of psychologi-
cal impact of severe adverse skin reactions as these may
impact on treatment compliance.
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